Patent · US Active

β-arrestin effectors and compositions and methods of use thereof

US8486885B2 · kind B2 · utility

5Cited by

7References

20Claims

0Family size

Assignee

TREVENA, INC. · US

Inventors

Dennis Yamashita · Cambridge, US
Xiao-Tao Chen · New York, US

Key dates

Filing date	Dec 28, 2009
Grant date	Jul 16, 2013
Priority date	—
Expiry date	Jul 19, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application describes a family of compounds acting as β-arrestin effectors. Such compounds may provide significant therapeutic benefit in the treatment of chronic and acute cardiovascular diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.